Research & Innovation, Vitals Magazine Fall 2026

Reprogramming Chronic Pain

How Dartmouth researchers are helping patients manage chronic pain through psychology, brain science, and digital therapeutics.

mixed media illustration of a woman in a ballet pose, with tendrils coming out of her leg and leading to a smartphone app called SpinePal

SpinePal, an app designed at Dartmouth, combines cognitive behavioral therapy, mindfulness, relaxation training, and recovery coaching to tackle tough-to-treat pain. Image courtesy of Madelyn Frumkin. Illustration by Laura Young and Heidi Allen-Goodrich.

Months after her spinal fusion, “Sarah” was still taking opioids for pain the operation had been supposed to fix. The incision had healed, and her scans looked normal. But ordinary movements still hurt, and the fear of making things worse was taking a toll on her daily life.

Sarah is one of nearly 60 million Americans living with chronic pain. Unlike acute pain, which warns of danger, chronic pain can persist long after tissues have recovered. Stress, poor sleep, inactivity, and trauma can sensitize the nervous system, amplifying pain and someone’s reactions to it.

Desperate for relief, Sarah enrolled in an early study testing SpinePal, a digital therapy designed at Dartmouth to help patients recover after spine surgery. The program reflects a growing recognition that chronic pain isn’t sustained by damaged biology alone, but by interactions among the brain, body, behavior, and lived experience.

Interrupting the Cycle

SpinePal was developed by psychologist Madelyn Frumkin, PhD, assistant professor of biomedical data science and of psychiatry at the Geisel School of Medicine at Dartmouth, and neurosurgeon Murray Echt, MD, assistant professor of surgery at Dartmouth Health’s Dartmouth Hitchcock Medical Center (DHMC). Delivered through a smartphone app, SpinePal combines cognitive behavioral therapy, mindfulness, relaxation training, and recovery coaching before and after surgery to reduce the fear, stress, and opioid reliance that can keep patients trapped in pain.

“People really vary in how they experience pain,” Frumkin notes. Some patients with extensive tissue damage may recover quickly, while others experience debilitating pain despite few visible signs of ongoing injury. Two patients may undergo the same surgery and exhibit nearly identical MRI scans, yet report dramatically different levels of pain.

That variability has stymied physicians and patients alike. For example, of the million-plus Americans who undergo spine surgery each year, 10 to 40% develop persistent pain, disability, or prolonged opioid use, according to studies published in Pain Medicine and Anesthesia & Analgesia. Roughly half of patients taking opioids before surgery continue using them afterward.

The missing piece isn’t always another procedure or prescription. Standard post-operative care rarely addresses psychosocial factors like depression, anxiety, fear of movement, and “catastrophizing”—the tendency to fixate on worst-case outcomes. But, Echt says, in clinical settings, “we see all the time that factors such as depression and anxiety lead to disability, and they predict outcomes after spine surgery more consistently than surgical or imaging factors.”

Tracking Pain in Real Life

Built to intervene during that window, SpinePal combines wearable biosensors with brief smartphone check-ins that ask patients about their pain, mood, activity, sleep, and recovery throughout the day. Together, those data create a much more detailed picture of healing than occasional clinic visits weeks or months after surgery.

To determine whether patients would use the program, Frumkin’s team interviewed 10 people (including Sarah) who continued using opioids for pain management months after spine surgery, walking them through SpinePal’s design and content to understand what resonated, what didn’t, and what they needed most during surgery.

At its core, the therapy works by targeting the thought patterns that can unintentionally keep pain cycling. “As cognitive behavioral therapists, we’re often helping people put thoughts on trial,” Frumkin says. “What evidence supports this fear? What evidence doesn’t? What happens if we respond differently?”

The goal isn’t convincing patients that their pain is imaginary—a misconception that has long stigmatized chronic pain. Instead, the therapy teaches people to recognize how fear, avoidance, and other learned responses can reinforce pain while building new ways to respond through movement, coping skills, and gradual reengagement with daily life.

Digital therapeutics may also address access problems that chronic pain patients often encounter. Pain psychologists remain scarce nationwide, especially in rural areas, leaving many without behavioral support during recovery. “Most people will never see a pain psychologist,” Frumkin says. “So we have to think about scalable ways to deliver these tools.”

Echt and Frumkin are now preparing a larger pilot study to test whether SpinePal improves recovery. Neither researcher promises the app will make Sarah’s pain disappear, or anyone else’s. What they’re testing is whether technology can change their relationship to pain, and if that’s enough to spare some of the millions of people still waiting for relief long after their wounds have healed.

To learn more about the Center for Technology and Behavioral Health at Dartmouth, contact Kim Labonte at 603-646-5110 or Kim.Labonte@dartmouth.edu.